Skip to main content
. 2017 Dec 15;8:1840. doi: 10.3389/fimmu.2017.01840

Table 1.

Baseline of all patients.

Baseline Cohort 1 Cohort 2
Total 113 140
Age
≤52 years 57 77
>52 years 55 63
Pathology
iDC 89 131
Non-iDC 24 9
Histology grade
0–I 9 19
II 72 111
III 26 7
Lymph nodes
Negative 81 84
Positive 28 52
Tumor size
≤3 cm 79 81
>3 cm 30 59
Stage
0–I 18 11
II 65 80
III–IV 29 47
ER
Negative 37 51
Positive 76 81
PR
Negative 44 61
Positive 69 71
HER2
Negative 62 95
Positive 29 37